1. Antidiabetic Effect of a New Original NT-3 Dipeptide Mimetic.
- Author
-
Yagubova SS, Chernyshevskaya MA, Ostrovskaya RU, Gudasheva TA, and Seredenin SB
- Subjects
- Mice, Animals, Dipeptides pharmacology, Neurons, Diabetes Mellitus, Experimental chemically induced, Diabetes Mellitus, Experimental drug therapy, Neuroprotective Agents pharmacology, Peptidomimetics pharmacology
- Abstract
It was previously established that the original dipeptide mimetic of the 4th loop of NT-3, hexamethylenediamide bis-(N-monosuccinyl-L-asparaginyl-L-asparagine) (GTS-301), has a pronounced neuroprotective effect in vitro at concentrations of 10
-5 -10-12 М. In the present study, experiments on the streptozotocin-induced diabetes model in C57Bl/6 mice showed that GTS-301, when administered intraperitoneally for 32 days at doses of 0.1 and 0.5 mg/kg, has antidiabetic activity manifested in a reduction of hyperglycemia and polydipsia and in an increase in animal survival. The results obtained confirm the concept of the similarity of neurochemical mechanisms underlying the regulation of functions of neurons and β-cells., (© 2023. Pleiades Publishing, Ltd.)- Published
- 2023
- Full Text
- View/download PDF